<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Pharmazac</title>
	<atom:link href="https://pharmazac.e.staging.generation-y.net/feed/" rel="self" type="application/rss+xml" />
	<link>https://pharmazac.e.staging.generation-y.net</link>
	<description></description>
	<lastBuildDate>Thu, 12 Feb 2026 12:50:54 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.4</generator>
	<item>
		<title>Mourkakos divests his business</title>
		<link>https://pharmazac.e.staging.generation-y.net/mourkakos-divests-his-business/</link>
		
		<dc:creator><![CDATA[epaminondas]]></dc:creator>
		<pubDate>Thu, 12 Feb 2026 12:50:52 +0000</pubDate>
				<category><![CDATA[Uncategorized]]></category>
		<guid isPermaLink="false">https://pharmazac.e.staging.generation-y.net/?p=1973</guid>

					<description><![CDATA[MsDMFJJF]]></description>
										<content:encoded><![CDATA[
<p>MsDMFJJF</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>PharmaZac sponsors the medical book “Epilepsy and Movement Disorders”</title>
		<link>https://pharmazac.e.staging.generation-y.net/pharmazac-sponsors-the-medical-book-epilepsy-and-movement-disorders-4/</link>
		
		<dc:creator><![CDATA[gyuser]]></dc:creator>
		<pubDate>Thu, 02 Nov 2023 22:45:59 +0000</pubDate>
				<category><![CDATA[Uncategorized]]></category>
		<guid isPermaLink="false">https://pharmazac.e.staging.generation-y.net/pharmazac-sponsors-the-medical-book-epilepsy-and-movement-disorders-4/</guid>

					<description><![CDATA[PharmaZac sponsors the medical book “Epilepsy and Movement Disorders” of Dr. A. Alexoudi Neurologist Ph.D of National and Kapodistrian University of Athens and Dr. S. Gatzonis,<span class="excerpt-hellip"> […]</span>]]></description>
										<content:encoded><![CDATA[<p>PharmaZac sponsors the medical book “Epilepsy and Movement Disorders” of Dr. A. Alexoudi Neurologist Ph.D of National and Kapodistrian University of Athens and Dr. S. Gatzonis, Professor of Neurology and Surgical Treatment of Neurological Diseases at National and Kapodistrian University of Athens.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Pharmazac launched the new product Cinacalcet</title>
		<link>https://pharmazac.e.staging.generation-y.net/pharmazac-launched-the-new-product-cinacalcet/</link>
		
		<dc:creator><![CDATA[gyuser]]></dc:creator>
		<pubDate>Thu, 02 Nov 2023 22:45:59 +0000</pubDate>
				<category><![CDATA[Uncategorized]]></category>
		<guid isPermaLink="false">https://pharmazac.e.staging.generation-y.net/pharmazac-launched-the-new-product-cinacalcet/</guid>

					<description><![CDATA[Pharmazac launched the new product Cinacalcet 30-60 and 90mg in F.C.Tablets. Cinacalcet indicated for the treatment of secondary Hyperparathyroidism (HPT) in adult patients with chronic kidney<span class="excerpt-hellip"> […]</span>]]></description>
										<content:encoded><![CDATA[<p>Pharmazac launched the new product Cinacalcet 30-60 and 90mg in F.C.Tablets. Cinacalcet indicated for the treatment of secondary Hyperparathyroidism (HPT) in adult patients with chronic kidney disease (CKD) on dialysis. Hypercalemia in adults patients with Parathyroid Carcinoma (PC) and Hypercalemia in adults patient with primary (HPT) for whom Parathyroid ectomy would be indicated on basis of serum calcium levels, but who are unable to undergo parathyroidectomy.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>We are welcoming KRKA in Greece</title>
		<link>https://pharmazac.e.staging.generation-y.net/we-are-welcoming-krka-in-greece/</link>
		
		<dc:creator><![CDATA[gyuser]]></dc:creator>
		<pubDate>Thu, 02 Nov 2023 22:45:59 +0000</pubDate>
				<category><![CDATA[Uncategorized]]></category>
		<guid isPermaLink="false">https://pharmazac.e.staging.generation-y.net/we-are-welcoming-krka-in-greece/</guid>

					<description><![CDATA[We are welcoming KRKA in Greece and we are supporting them as their distributor! Pharmazac iw happy to announce that it will begin in December ΄20<span class="excerpt-hellip"> […]</span>]]></description>
										<content:encoded><![CDATA[<p>We are welcoming KRKA in Greece and we are supporting them as their distributor!</p>
<p>Pharmazac iw happy to announce that it will begin in December ΄20 the distribution of the products of KRKA and TAD in Greece. KRKA is a global leader in healthcare with more 50 million of patients using its products on a daily basis.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>We are becoming a manufacturer and key player in radiopharmaceuticals</title>
		<link>https://pharmazac.e.staging.generation-y.net/we-are-becoming-a-manufacturer-and-key-player-in-radiopharmaceuticals/</link>
		
		<dc:creator><![CDATA[gyuser]]></dc:creator>
		<pubDate>Thu, 02 Nov 2023 22:45:59 +0000</pubDate>
				<category><![CDATA[Uncategorized]]></category>
		<guid isPermaLink="false">https://pharmazac.e.staging.generation-y.net/we-are-becoming-a-manufacturer-and-key-player-in-radiopharmaceuticals/</guid>

					<description><![CDATA[We are becoming a manufacturer and key player in radiopharmaceuticals ! Pharmazac is happy to announce that its radiopharmaceuticals manufacturing unit in the industrial zone of<span class="excerpt-hellip"> […]</span>]]></description>
										<content:encoded><![CDATA[<p>We are becoming a manufacturer and key player in radiopharmaceuticals !</p>
<p>Pharmazac is happy to announce that its radiopharmaceuticals manufacturing unit in the industrial zone of Lamia (Greece) we will be fully operational from Q3/2021.</p>
<p>We are hosting a state-of-the-art Cyclotron in a newly built modern facility, designed in collaboration with General Electric.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>We are exhibiting and partnering</title>
		<link>https://pharmazac.e.staging.generation-y.net/we-are-exhibiting-and-partnering/</link>
		
		<dc:creator><![CDATA[gyuser]]></dc:creator>
		<pubDate>Thu, 02 Nov 2023 22:45:59 +0000</pubDate>
				<category><![CDATA[Uncategorized]]></category>
		<guid isPermaLink="false">https://pharmazac.e.staging.generation-y.net/we-are-exhibiting-and-partnering/</guid>

					<description><![CDATA[With Covid-19 on the way of most of our exhibiting activities, Pharmazac has joined in 2020 the largest pharmaceutical partnering events and has participated in more<span class="excerpt-hellip"> […]</span>]]></description>
										<content:encoded><![CDATA[<p>With Covid-19 on the way of most of our exhibiting activities,<br />
Pharmazac has joined in 2020 the largest pharmaceutical partnering events and<br />
has participated in more than 165 meetings at CPhI festival, EuroPLX and PHARMA SYNERGY.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Pharmazac launched the new product Zaolin/Vinorelbin</title>
		<link>https://pharmazac.e.staging.generation-y.net/pharmazac-launched-the-new-product-zaolin-vinorelbin/</link>
		
		<dc:creator><![CDATA[gyuser]]></dc:creator>
		<pubDate>Thu, 02 Nov 2023 22:45:59 +0000</pubDate>
				<category><![CDATA[Uncategorized]]></category>
		<guid isPermaLink="false">https://pharmazac.e.staging.generation-y.net/pharmazac-launched-the-new-product-zaolin-vinorelbin/</guid>

					<description><![CDATA[Pharmazac launched the new product Zaolin/Vinorelbin the first generic version for oral use ( soft gelatin caps) in Greece. Zaolin/Vinorelbin is a chemotherapy drug used to<span class="excerpt-hellip"> […]</span>]]></description>
										<content:encoded><![CDATA[<p>Pharmazac launched the new product Zaolin/Vinorelbin the first generic version for oral use ( soft gelatin caps) in Greece.<br />
Zaolin/Vinorelbin is a chemotherapy drug used to treat non-small cell lung cancer and breast cancer.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>We are investing in our new pharmaceuticals manufacturing site.</title>
		<link>https://pharmazac.e.staging.generation-y.net/we-are-investing-in-our-new-pharmaceuticals-manufacturing-site/</link>
		
		<dc:creator><![CDATA[gyuser]]></dc:creator>
		<pubDate>Thu, 02 Nov 2023 22:45:59 +0000</pubDate>
				<category><![CDATA[Uncategorized]]></category>
		<guid isPermaLink="false">https://pharmazac.e.staging.generation-y.net/we-are-investing-in-our-new-pharmaceuticals-manufacturing-site/</guid>

					<description><![CDATA[Pharmazac is working on its latest investment a new site of 10.000 sq.m for pharmaceuticals manufacturing, in the industrial zone of Keratea near Athens area .<span class="excerpt-hellip"> […]</span>]]></description>
										<content:encoded><![CDATA[<p>Pharmazac is working on its latest investment a new site of 10.000 sq.m for pharmaceuticals manufacturing, in the industrial zone of Keratea near Athens area .<br />
Our site will be operational by 2022.<br />
Pharmazac is a top investor in pharmaceuticals and diagnostics, with two ongoing greenfield projects and more than eight projects completed every year.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Pharmazac launched the new product Petasitis Hybridus (Petagran)</title>
		<link>https://pharmazac.e.staging.generation-y.net/pharmazac-launched-the-new-product-petasitis-hybridus-petagran/</link>
		
		<dc:creator><![CDATA[gyuser]]></dc:creator>
		<pubDate>Thu, 02 Nov 2023 22:45:15 +0000</pubDate>
				<category><![CDATA[Uncategorized]]></category>
		<guid isPermaLink="false">https://pharmazac.e.staging.generation-y.net/pharmazac-launched-the-new-product-petasitis-hybridus-petagran/</guid>

					<description><![CDATA[Pharmazac has developed in its laboratories and launched in the Greek pharmaceutical market a nutraceutical, the titrate extract of Petasitis Hybridus in liquid hard gelatin capsules<span class="excerpt-hellip"> […]</span>]]></description>
										<content:encoded><![CDATA[<p class="x_MsoNormal"><span lang="EN-US">Pharmazac has developed in its laboratories and launched in the Greek pharmaceutical market a nutraceutical, the titrate extract of <i>Petasitis Hybridus </i>in liquid hard gelatin capsules of 70,4 mg P A free, under the trade name Petagran.</span></p>
<p class="x_MsoNormal"><span lang="EN-US">Petagran / <i>Petasitis hybridus</i> is effective in reducing the frequency and severity of migraine attracts.</span></p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>5 -16 October 2020, Online CPhI festival of pharma</title>
		<link>https://pharmazac.e.staging.generation-y.net/5-16-october-2020-online-cphi-festival-of-pharma/</link>
		
		<dc:creator><![CDATA[gyuser]]></dc:creator>
		<pubDate>Thu, 02 Nov 2023 22:45:15 +0000</pubDate>
				<category><![CDATA[Uncategorized]]></category>
		<guid isPermaLink="false">https://pharmazac.e.staging.generation-y.net/5-16-october-2020-online-cphi-festival-of-pharma/</guid>

					<description><![CDATA[Pharmazac S.A participates in the online CPhI festival of pharma 2020]]></description>
										<content:encoded><![CDATA[<p>Pharmazac S.A participates in the online CPhI festival of pharma 2020</p>
]]></content:encoded>
					
		
		
			</item>
	</channel>
</rss>
